Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Regulação e direito · 29/09/20151 min de leitura
Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events
Tradução automática local · Idioma original da fonte
Resumo
The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) will be providing a Single Source Competition Supplement to Harvard Pilgrim Healthcare, an awardee of the Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events Cooperative Agreement. The single source supplement will fund research utilizing proprietary methods to improve sepsis prevention by better defining the burden, preventability and identifying measurers to track progress.
Idioma original da fonte: Federal Register — All DocumentsAbrir o comunicado original →